Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-011300
Filing Date
2025-03-07
Accepted
2025-03-07 16:16:41
Documents
1
Period of Report
2025-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741382194.html 4  
1 FORM 4 wk-form4_1741382194.xml 4 3551
  Complete submission text file 0001628280-25-011300.txt   5012
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Alva Emily Peterson (Reporting) CIK: 0001738422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 25720295